Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis-Reference-Cited by-同舟云学术

Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis

Published:2011-12-06 Issue:3 Volume:67 Page:413-423
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:

Author:

Jensen J. M.,Scherer A.,Wanke C.,Bräutigam M.,Bongiovanni S.,Letzkus M.,Staedtler F.,Kehren J.,Zuehlsdorf M.,Schwarz T.,Weichenthal M.,Fölster-Holst R.,Proksch E.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1398-9995.2011.02747.x/fullpdf

Reference34 articles.

1. Corticosteroid effects on cell signaling;Barnes;Eur Respir J,2006

2. Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus;Stuetz;Int Arch Allergy Immunol,2006

3. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506complexes;Liu;Cell,1991

4. Integration of Notch 1 and calcineurin/NFAT signaling pathways in keratinocyte growth and differentiation control;Mammucari;Dev Cell,2005

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating multi‐omics approaches in deciphering atopic dermatitis pathogenesis and future therapeutic directions;Allergy;2024-06-04

2. Atopic dermatitis-associated genetic variants regulate LOC100294145 expression implicating interleukin-27 production and type 1 interferon signaling;World Allergy Organization Journal;2024-02

3. Inhibition of gasdermin D (GSDMD) as a promising therapeutic approach for atopic dermatitis;International Immunopharmacology;2023-11

4. A Comparison of Topical Corticosteroids and Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis;The Journal of Allergy and Clinical Immunology: In Practice;2023-05

5. Targeting Skin Barrier Function in Atopic Dermatitis;The Journal of Allergy and Clinical Immunology: In Practice;2023-05